Overview
KPV is a short tripeptide fragment (Lys-Pro-Val) derived from the C-terminal sequence of α-melanocyte-stimulating hormone (α-MSH). In laboratory research settings, KPV has been studied for its interaction with immune-related signaling pathways and regulatory mechanisms involved in inflammatory response modulation.
This compound is supplied strictly for laboratory and investigational research purposes.
Compound Breakdown
As a defined signaling fragment of α-MSH, KPV has been investigated in preclinical research models for its ability to influence:
Cytokine-associated signaling pathways
Immune cell activation and regulation mechanisms
NF-κB–related signaling modulation
Peptide-mediated immune response control
Its minimal structure allows researchers to study targeted signaling effects without broader peptide activity.
Research Context
Research investigations involving KPV commonly explore:
Immunomodulatory signaling pathways
Inflammatory response regulation models
Comparative studies of α-MSH–derived peptide fragments
Combination research frameworks involving tissue- and immune-focused peptides
These investigations remain limited to controlled laboratory environments and do not imply clinical or therapeutic outcomes.
Related Categories
KPV is frequently evaluated alongside BPC-157 Peptide in immune-related research models and is also incorporated into combination research formulations such as the KLOW Blend.
